Forward Looking Statements





When used in this Form 10-K and in future filings by the Company with the
Commission, The words or phrases such as "anticipate," "believe," "could,"
"would," "should," "estimate," "expect," "intend," "may," "plan," "predict,"
"project," "will," "try" or similar expressions are intended to identify
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance
on any such forward looking statements, each of which speak only as of the date
made. Such statements are subject to certain risks and uncertainties that could
cause actual results to differ materially from historical earnings and those
presently anticipated or projected. The Company has no obligation to publicly
release the result of any revisions which may be made to any forward-looking
statements to reflect anticipated or unanticipated events or circumstances
occurring after the date of such statements.



These forward-looking statements involve known and unknown risks, uncertainties
and other factors that may cause actual results to be materially different.
These factors include, but are not limited to, changes that may occur to general
economic and business conditions; changes in current pricing levels that we can
charge for our services or which we pay to our suppliers and business partners;
changes in political, social and economic conditions in the jurisdictions in
which we operate; changes to regulations that pertain to our operations; changes
in technology that render our technology relatively inferior, obsolete or more
expensive compared to others; foreign currency fluctuations; changes in the
business prospects of our business partners and customers; increased
competition, including from our business partners; delays in the delivery of
broadband capacity to the homes and offices of persons who use our services;
general disruptions to Internet service; and the loss of customer faith in the
Internet as a means of commerce.

   23


  Table of Contents



The following discussion should be read in conjunction with the financial statements and related notes which are included in this report under Item 8.

We do not undertake to update our forward-looking statements or risk factors to reflect future events or circumstances.





Overview



Critical Accounting Policies


Basis of Presentation and Principles of Consolidation


The Company's consolidated financial statements and the notes thereto have been
prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in
the United States of America. The consolidated financial statements include Real
Brands, and its wholly owned subsidiaries. DePetrillo Real Estate Holdings, LLC
is a wholly owned subsidiary of CASH Acquisition Corp. and the owner of the
Company's building in Rhode Island. American Standard Hemp Inc. is a wholly
owned subsidiary of CASH Acquisition Corp. All significant intercompany accounts
and transactions have been eliminated.



Use of estimates and judgments





The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the consolidated financial statements and the reported amounts of
expenses during the reporting period. Key areas of estimation include the
estimated useful lives of property, plant, equipment and intangibles assets and
liabilities, income taxes, and the valuation of stock-based compensation. Due to
the uncertainty inherent in such estimates, actual results may differ from

the
Company's estimates.



Accounting standard updates



From time to time, new accounting pronouncements are issued by the Financial
Accounting Standards Board ("FASB") or other standard setting bodies that are
adopted by the Company as of the specified effective date. Unless otherwise
discussed, the Company believes that the effect of recently issued standards
that are not yet effective will not have a material effect on its consolidated
financial position or results of operations upon adoption.



Segment Reporting



The Company operates as one segment, in which management uses one measure of
profitability, and all of the Company's assets are located in the United States
of America. The Company does not operate separate lines of business or separate
business entities with respect to any of its product candidates. Accordingly,
the Company does not have separately reportable segments.

   24


  Table of Contents




Cash and Cash Equivalents


The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be a cash equivalent.

Accounts Receivable and Allowance for Doubtful Accounts





The Company performs periodic credit evaluations of its customers' financial
conditions and generally does not require collateral. The Company reviews all
outstanding accounts receivable for collectability on a quarterly basis. An
allowance for doubtful accounts is recorded for any amounts deemed
uncollectable. The Company does not accrue interest receivable on past due
accounts receivable.



Concentrations of Credit Risk





The Company, from time to time during the years covered by these consolidated
financial statements, may have bank balances in excess of its insured limits.
Management has deemed this a normal business risk.



Inventory



Inventory is comprised of raw hemp and hemp oil in different phases of
production to completion of final product. Products include tinctures, creams
and lotions. Inventory is valued at cost. No packaging material of any kind is
included in inventory. Packaging materials are expensed as incurred.



Property and Equipment



On February 15, 2020 the Company purchased DePetrillo Real Estate Holdings, LLC,
a Rhode Island Limited Liability Company having as its only asset the building
at 12 Humbert Street in North Providence Rhode Island. The building is the
Company's headquarters and a hemp processing facility. The purchase price of the
building was 2 million shares of CASH common stock, $25,000 in cash and the
assumption of the mortgage which at the time was $189,916. The prior owner
agreed to put the $25,000 payment into building improvements. The building and
land were appraised at $475,000. The building is being depreciated over 15 years
on a straight-line basis starting October 1, 2021. Depreciation expense on the
building for the year ended December 31, 2022 was $29,687.



The Company made $785,823 in building improvements since purchasing the building. Building improvements is being depreciated over 15 years commencing from the completion of the work, October 1, 2021. Depreciation expense on building improvements for the year ended December 31, 2022 was $52,388.


Property and equipment are recorded at cost. Depreciation is computed using the
straight-line method over estimated useful lives of five years. On December 31,
2021 the Company wrote down the value of the equipment to $0 because the
equipment had been sitting idle for over a year resulting in a loss on disposal
of assets of $385,989. The furniture and equipment and related accumulated
depreciation were removed from the books as of December 31, 2021. Total
depreciation expense for the year ended December 31, 2022 was $82,706.
Expenditures for repairs and maintenance are expensed as incurred.

   25


  Table of Contents



Impairment of Long-Lived Assets





The Company reviews long-lived assets, including property and equipment, for
impairment whenever events or changes in business circumstances indicate that
the carrying amount of the assets may not be fully recoverable. Factors that the
Company considers in deciding when to perform an impairment review include
significant underperformance of the business in relation to expectations,
significant negative industry or economic trends, and significant changes or
planned changes in the use of the assets. If an impairment review is performed
to evaluate long-lived asset for recoverability, the Company compares forecasts
of undiscounted cash flows expected to result from the use and eventual
disposition of the long-lived asset to its carrying value. An impairment loss
would be recognized when estimated undiscounted future cash flows expected to
result from the use of an asset over its fair value, determined based on
discounted cash flows is less than the carrying value on the books of the
Company.



Revenue Recognition



The Company follows, ASC 606 Revenue from Contracts with Customers which
establishes a single and comprehensive framework and sets out how much revenue
is to be recognized, and when. The core principle is that a vendor should
recognize revenue to depict the transfer of promised goods or services to
customers in an amount that reflects the consideration to which the vendor
expects to be entitled in exchange for those goods or services. Revenue will now
be recognized by a vendor when control over the goods or services is transferred
to the customer. In contrast, Revenue based revenue recognition is around an
analysis of the transfer of risks and rewards; this now forms one of a number of
criteria that are assessed in determining whether control has been transferred.
The application of the core principle in ASC 606 is carried out in five steps:
Step 1 - Identify the contract with a customer: a contract is defined as an
agreement (including oral and implied), between two or more parties, that
creates enforceable rights and obligations and sets out the criteria for each of
those rights and obligations. The contract needs to have commercial substance
and it is probable that the entity will collect the consideration to which it
will be entitled. Step 2 - Identify the performance obligations in the contract:
a performance obligation in a contract is a promise (including implicit) to
transfer a good or service to the customer. Each performance obligation should
be capable of being distinct and is separately identifiable in the contract.
Step 3 - Determine the transaction price: transaction price is the amount of
consideration that the entity can be entitled to, in exchange for transferring
the promised goods and services to a customer, excluding amounts collected on
behalf of third parties. Step 4 - Allocate the transaction price to the
performance obligations in the contract: for a contract that has more than one
performance obligation, the entity will allocate the transaction price to each
performance obligation separately, in exchange for satisfying each performance
obligation. The acceptable methods of allocating the transaction price include
adjusted market assessment approach, expected cost plus a margin approach, and
the residual approach in limited circumstances. Discounts given should be
allocated proportionately to all performance obligations unless certain criteria
are met and reallocation of changes in standalone selling prices after inception
is not permitted. Step 5 - Recognize revenue as and when the entity satisfies a
performance obligation: the entity should recognize revenue at a point in time,
except if it meets any of the three criteria, which will require recognition of
revenue over time: the entity's performance creates or enhances an asset
controlled by the customer, the customer simultaneously receives and consumes
the benefit of the entity's performance as the entity performs, and the entity
does not create an asset that has an alternative use to the entity and the
entity has the right to be paid for performance to date.



Stock-based Compensation


The Company expenses stock-based compensation to employees and consultants based on the fair value at grant date, which generally is the agreement date the Company entered into with employees or consultants. To date the Company has issued restricted common stock shares and preferred stock.



   26


  Table of Contents



Beneficial Conversion Features of Convertible Securities


Conversion options that are not bifurcated as a derivative pursuant to ASC 815
and not accounted for as a separate equity component under the cash conversion
guidance are evaluated to determine whether they are beneficial to the investor
at inception (a beneficial conversion feature) or may become beneficial in the
future due to potential adjustments. The beneficial conversion feature guidance
in ASC 470-20 applies to convertible stock as well as convertible debt which are
outside the scope of ASC 815. A beneficial conversion feature is defined as a
nondetachable conversion feature that is in the money at the commitment date.
The beneficial conversion feature guidance requires recognition of the
conversion option's in-the-money portion, the intrinsic value of the option, in
equity, with an offsetting reduction to the carrying amount of the instrument.
The resulting discount is amortized as a dividend over either the life of the
instrument, if a stated maturity date exists, or to the earliest conversion
date, if there is no stated maturity date. If the earliest conversion date is
immediately upon issuance, the dividend must be recognized at inception. When
there is a subsequent change to the conversion ratio based on a future
occurrence, the new conversion price may trigger the recognition of an
additional beneficial conversion feature on occurrence.



Derivatives



The Company reviews the terms of convertible debt issued to determine whether
there are embedded derivative instruments, including embedded conversion
options, which are required to be bifurcated and accounted for separately as
derivative financial instruments. In circumstances where the host instrument
contains more than one embedded derivative instrument, including the conversion
option, that is required to be bifurcated, the bifurcated derivative instruments
are accounted for as a single, compound derivative instrument.



Bifurcated embedded derivatives are initially recorded at fair value and are
then revalued at each reporting date with changes in the fair value reported as
non-operating income or expense. When the equity or convertible debt instruments
contain embedded derivative instruments that are to be bifurcated and accounted
for as liabilities, the total proceeds received are first allocated to the fair
value of all the bifurcated derivative instruments. The remaining proceeds, if
any, are then allocated to the host instruments themselves, usually resulting in
those instruments being recorded at a discount from their face value. The
discount from the face value of the convertible debt, together with the stated
interest on the instrument, is amortized over the life of the instrument through
periodic charges to interest expense.



Net Loss Per Common Share



Basic net loss per common share is computed by dividing net loss by the
weighted-average number of common shares outstanding during the period.
Potential common stock equivalents are determined using the treasury stock
method. For diluted net loss per share purposes, the Company excludes stock
options and other stock-based awards, including shares issued as a result of
option exercises that are subject to repurchase by the Company, whose effect
would be anti-dilutive from the calculation. During the year ended December 31,
2022 and 2021, common stock equivalents were excluded from the calculation of
diluted net loss per common share, as their effect was anti-dilutive due to the
net loss incurred. Therefore, basic and diluted net loss per share was the

same
in all periods presented.



The Company had 154,518,887 and 30,192,079 potentially dilutive options and
convertible securities, respectively, that have been excluded from the
computation of diluted weighted-average shares outstanding as of December 31,
2022, and 154,518,887 and 28,443,298 potentially dilutive options and
convertible securities, respectively, that have been excluded from the
computation of diluted weighted-average shares outstanding as of December 31,
2021, as they would be anti-dilutive.

   27


  Table of Contents




Treasury Stock


The Company accounts for treasury stock under the cost method and includes treasury stock as a component of stockholder's deficit.

Fair Value of Financial Instruments


The guidance for fair value measurements, ASC 820, Fair Value Measurements and
Disclosures, establishes the authoritative definition of fair value, sets out a
framework for measuring fair value, and outlines the required disclosures
regarding fair value measurements. Fair value is the price that would be
received to sell an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in an orderly
transaction between market participants at the measurement date. The Company
uses a three-tier fair value hierarchy based upon observable and non-observable
inputs as follow:


• Level 1 - Quoted market prices in active markets for identical assets and


        liabilities;



• Level 2 - Inputs, other than level 1 inputs, either directly or indirectly


        observable; and




      • Level 3 - Unobservable inputs developed using internal estimates and
        assumptions (there is little or no market date) which reflect those that
        market participants would use.


The Company records its derivative activities at fair value. As of December 31, 2022, no derivative liabilities are recorded.

Off Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.





Uncertain Tax Positions



The Company did not take any uncertain tax positions and had no adjustments to
unrecognized income tax liabilities or benefits pursuant to the provisions of
Section 740-10-25 for the year ended December 31, 2022.



 Income Taxes



The Company accounts for income taxes under Section 740-10-30 of the FASB
Accounting Standards Codification. Deferred income tax assets and liabilities
are determined based upon differences between the financial reporting and tax
basis of assets and liabilities and are measured using the enacted tax rates and
laws that will be in effect when the differences are expected to reverse.
Deferred tax assets are reduced by a valuation allowance to the extent
management concludes it is more likely than not that the assets will not be
realized. Deferred tax assets and liabilities are measured using enacted tax
rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled. The effect on deferred tax
assets and liabilities of a change in tax rates is recognized in the
consolidated statements of operations in the period that includes the enactment
date.

   28


  Table of Contents



Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.





The Company accounts for stock-based compensation for employees and directors in
accordance with Accounting Standards Codification 718, Compensation ("ASC 718")
as issued by the FASB. ASC 718 requires all share-based payments to employees,
including grants of employee stock options, to be recognized in the statement of
operations based on their fair values. Under the provisions of ASC 718,
stock-based compensation costs are measured at the grant date, based on the fair
value of the award, and are recognized as an expense over the employee's
requisite service period (generally the vesting period of the equity grant). The
fair value of the Company's common stock options is estimated using the Black
Scholes option-pricing model with the following assumptions: expected
volatility, dividend rate, risk free interest rate and the expected life. The
Company expenses stock-based compensation by using the straight-line method. In
accordance with ASC 718 and, excess tax benefits realized from the exercise of
stock-based awards are classified as cash flows from operating activities. All
excess tax benefits and tax deficiencies (including tax benefits of dividends on
share-based payment awards) are recognized as income tax expense or benefit in
the condensed consolidated statements of operations. The Company accounts for
stock-based compensation awards issued to non-employees for services, as
prescribed by ASC 718-10, at either the fair value of the services rendered or
the instruments issued in exchange for such services, whichever is more readily
determinable, using the measurement date guidelines enumerated in Accounting
Standards Update ("ASU") 2018-07.



In February 2016, the FASB issued ASU 2016-02, "Leases" Topic 842, which amends
the guidance in former ASC Topic 840, Leases. The new standard increases
transparency and comparability most significantly by requiring the recognition
by lessees of right-of-use assets and lease liabilities on the balance sheet for
all leases longer than 12 months. Under the standard, disclosures are required
to meet the objective of enabling users of financial statements to assess the
amount, timing, and uncertainty of cash flows arising from leases. For lessees,
leases will be classified as finance or operating, with classification affecting
the pattern and classification of expense recognition in the income statement.
The Company adopted the new lease guidance effective January 1, 2019. The
Company is not a party to any leases and therefore is not showing any asset or
liability related to leases in the current period or prior periods.





ASC 740 prescribes a comprehensive model for how companies should recognize,
measure, present, and disclose in their financial statements uncertain tax
positions taken or expected to be taken on a tax return. Under ASC 740, tax
positions must initially be recognized in the financial statements when it is
more likely than not the position will be sustained upon examination by the tax
authorities. Such tax positions must initially and subsequently be measured as
the largest amount of tax benefit that has a greater than 50% likelihood of
being realized upon ultimate settlement with the tax authority assuming full
knowledge of the position and relevant facts.



   29


  Table of Contents






Subsequent Events



In March 2023, for each of the years 2021, 2022 and 2023, for which no
compensation was given to the directors, each non-employee director was granted,
as compensation for serving as a director, five-year non-qualified stock options
to purchase 6,143,628 shares of the Company's common stock at an exercise price
equal to the last reported trading price of our common stock on the day of grant
(i.e. 3/22/23), with the options granted for 2021 and 2022 vesting immediately
and the options granted for 2023 to vest on December 31, 2023, provided the
director serves for at least six months, following the date of grant. In
addition to these option grants, each director shall receive an additional
500,000 options to vest on December 31, 2023, provided the director serves for
at least six months, following the date of grant. Total options granted to
Directors was 94,654,420 at an exercise price of $0.0071.

In March 2023 as consideration for deferring his compensation over the last two
years, Thom Kidrin the Chairman and CEO was granted five-year non-qualified
stock options to purchase 50,000,000 shares of the Company's common stock at an
exercise price equal to the last reported trading price of our common stock on
the date of grant (i.e. 3/22/23) and to vest immediately. Exercise price is
$0.0071.

On December 21, 2022, the Company received written notice from the OTC Markets
Group ("OTC") notifying the Company that its common shares, $0.001 par value,
closed below $0.01 per share for more than 30 consecutive calendar days and no
longer meets the Standards for Continued Eligibility for OTCQB as per the OTCQB
Standards, Section 2.3(2), which states that the Company must "maintain
proprietary priced quotations published by a Market Maker in OTC Link with a
minimum closing bid price of $.01 per share on at least one of the prior thirty
consecutive calendar days." As per Section 4.1 of the OTCQB Standards, the
Company was granted a cure period of 90 calendar days during which the minimum
closing bid price for the Company's common stock must be $0.01 or greater for
ten consecutive trading days in order to continue trading on the OTCQB
marketplace.

This requirement was not met by March 22, 2023, so the Company's common stock was removed from the OTCQB marketplace.



The Company evaluates events that have occurred after the balance sheet date but
before the financial statements are issued. Based upon the evaluation, the
Company did not identify any additional recognized or non-recognized subsequent
events that would have required adjustment or disclosure in the financial
statements.

   30


  Table of Contents




General



The Company's primary business is hemp CBD oil/isolate extraction, wholesaling
of CBD oils and isolate, and production and sales of hemp-derived CBD consumer
brands. The Company's brand development strategy will be to leverage existing
Company resources into creating online sales, licensing opportunities and a
distribution network for proprietary legal hemp.



Components of Statements of Operations





Revenue



Product revenue consists of sales of CBD oils, tinctures and creams under our
own brand name and white labeled along with wholesale sale of isolate and
distillate oils net of returns, discounts and allowances. Once a purchase order
is received, the order is packaged and shipped to the customer. Depending on the
customer, some orders are paid at the time of purchase and others have 30 day
terms. We recognize the revenue when the order is delivered and received by

the
customer.



Cost of Goods Sold


Cost of goods sold represents costs of raw material, packaging, printing and labels, prepackaged goods for sale and the write down of any non-moving components of inventory.

We expect our cost of goods sold per unit to decrease as we scale our operations, improve product designs and work with our third-party suppliers to lower costs.



Operating Expenses



General and Administrative.



Our general and administrative expenses consist primarily of compensation,
benefits, travel and other costs for employees. In addition, general and
administrative expenses include third-party consulting, accounting services,
repairs and maintenance, utilities for our building and information technology.
We expect general and administrative expenses to increase as we grow our
business and add additional employees.



Professional Fees


Professional fees consist of legal fees and audit fees.





Interest Expense


Interest expense consists primarily of interest from notes due to debtholders and interest on the mortgage.

Liquidity and Capital Resources





We had limited operations during 2022 due to a lack of funds to purchase
inventory and to market our products. We continue to pursue additional sources
of capital though we have no current arrangements with respect to, or sources
of, additional financing at this time and there can be no assurance that any
such financing will become available. We will need to raise additional capital
in order to execute on our business plan. We intend on raising additional
capital in the short term by selling equity through private placements.

   31


  Table of Contents




RESULTS OF OPERATIONS


Year ended December 31, 2022 compared to year ended December 31, 2021


Revenue was $11,133 for the year ended December 31, 2022 and $5,546 for the year
ended December 31, 2021. The Company was unable to raise the funds to purchase
inventory and execute on its marketing plan during the year. We still need to
raise a sufficient amount of capital to provide the resources required that
would enable us to execute our business plan.



Cost of goods sold decreased by $255,113 from $262,620 for the year ended
December 31, 2021 to $7,507 for the year ended December 31, 2022. The decrease
is attributable the Company writing off the value of the old inventory due to
lack of movement of the inventory for over one year due to the pandemic in 2021.



General and administrative (G & A) expenses decreased by $219,189 from $471,494
to $252,305 for the year ended December 31, 2022.  The decrease is due to a
decrease in activity around the renovation and build out of the new facility and
the raising of funds in order to facilitate that process. That was completed in
2021.

Professional fees expenses decreased by $71,986 from $194,556 to $122,570 for
the year ended December 31, 2022.  The decrease is due to a decrease in activity
in raising funds, the additional expense involved in registering our stock with
the SEC and becoming a public reporting company in 2021,and an overall decrease
in business activity.

Payroll and related expenses increased by $93,688 to $420,112 from $326,424 for
the year ended December 31, 2022. The increase is primarily due to hiring one
new person to run the Phaze product line.



For the year ended December 31, 2021, the Company recorded an option expense of
$1,065,390. All options were fully vested in 2021 resulting in no option expense
in 2022.


For the year ended December 31, 2021, the Company had a forgiveness of PPP debt of $143,485. All of the Company's PPP debt was forgiven in 2021.

For the year ended December 31, 2022, the Company had interest expense of $32,507. For the year ended December 31, 2021, the Company had interest expense of $33,040.





For the year ended December 31, 2021, the Company recorded a loss on disposal of
a assets of $385,989. The Company wrote down the value of the equipment due to
there being no use of the equipment for an extended period of time related to
the pandemic and renovations to the new facility.

For the year ended December 31, 2021, the Company had a warrant expense of $37,753 for warrants issued to extend the term of the convertible debt. Warrant expense for the year ended December 31, 2022 was $0.

As a result of the foregoing, we had a net loss of $905,944 for the year ended December 31, 2022 compared to a net loss of $2,795,771 for the year ended December 31, 2021.



   32


  Table of Contents



Liquidity and Capital Resources





As of December 31, 2022, the Company had cash and cash equivalents of a $2,845
as compared to $197,255 as of December 31, 2021, representing a decrease of
$194,410. As of December 31, 2022, the Company had a working capital deficit of
$1,785,530 as compared to a working capital deficit of $1,103,739 as of December
31, 2021, representing an increase in the deficit of $681,791.



The Company is seeking additional capital in the private and/or public equity
markets to continue operations and build inventory, sales, marketing, brand and
distribution. The Company is currently evaluating additional equity and debt
financing opportunities and may execute them when appropriate. However, there
can be no assurances that the Company can consummate such a transaction or
consummate a transaction at favorable prices.



Company plans on increased sales of its products in the market. However, there can be no assurances that the sales will increase or that even if they do increase that it will increase sufficiently to generate the necessary cash.



   33


  Table of Contents



ITEM 8. FINANCIAL STATEMENTS.



                              CONTENTS

  REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM       35

  CONSOLIDATED BALANCE SHEETS                                   39

  CONSOLIDATED STATEMENTS OF OPERATIONS                         40

  CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY                41

  CONSOLIDATED STATEMENTS OF CASH FLOWS                         42

  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS                    43







   34


  Table of Contents




                               [[Image Removed]]





            REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors and

Stockholders of Real Brands, Inc.

Opinion on the Financial Statements



We have audited the accompanying consolidated balance sheets of Real Brands,
Inc. (the Company) as of December 31, 2022, and the related consolidated
statements of operations, stockholders' equity, and cash flows for the one-year
period ended December 31, 2022, and the related notes (collectively referred to
as the financial statements). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial position of
the Company as of December 31, 2022, and the results of its operations and its
cash flows for the one-year period ended December 31, 2022, in conformity with
accounting principles generally accepted in the United States of America. The
consolidated financial statement of Real Brands, Inc. as of December 31, 2021
were audited by other auditors whose report dated April 6, 2022 expressed an
unqualified opinion on those statements.

Going Concern



The accompanying consolidated financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 1 to the
financial statements, the Company has recurring net losses and negative cash
flows from operations which raises substantial doubt about its ability to
continue as a going concern. Management's plans regarding those matters are also
described in Note 1. The consolidated financial statements do not include any
adjustments that might result from the outcome of this uncertainty.

Basis for Opinion



These consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's
consolidated financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement, whether due to error or fraud. The Company is not required to
have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audits, we are required to obtain an
understanding of internal control over financial reporting, but not for the
purpose of expressing an opinion on the effectiveness of the Company's internal
control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or
fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and
disclosures in the financial statements. Our audits also included evaluating the
accounting principles used and significant estimates made by management, as well
as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matter



The critical audit matter communicated below are matters arising from the
current period audit of the consolidated financial statements that were
communicated or required to be communicated to the audit committee and that: (1)
relate to accounts or disclosures that are material to the financial statements
and (2) involved our especially challenging, subjective, or complex judgments.
The communication of critical audit matter does not alter in any way our opinion
on the consolidated financial statements, taken as a whole, and we are not, by
communicating the critical audit matter below, providing separate opinions on
the critical audit matter or on the accounts or disclosures to which they
relate.



   35


   Contents




Going Concern

As discussed in Note 1 to the consolidated financial statements, the Company has recurring net losses and negative cash flows from operations.

Auditing management's evaluation of a going concern can be a significant judgement given the fact that the Company uses management estimates on future revenues and expenses which are not able to be substantiated.



To evaluate the appropriateness of the going concern, we examined and evaluated
the financial information that was the initial cause along with management's
plans to mitigate going concern and management's disclosure on going concern.



/s/ M&K CPAS, PLLC

We have served as the Company's auditor since 2023.



Firm ID 2738

Houston, TX

April 28, 2023



   36


   Contents




[[Image Removed]]

            REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Board of Directors and Stockholders of

Real Brands, Inc. and Its Subsidiaries:

Opinion on the Financial Statements



We have audited the accompanying balance sheets of Real Brands, Inc. and its
subsidiaries ("the Company") as of December 31, 2021 and December 31, 2020 and
the related statements of operations, stockholders' deficit, cash flows and the
related notes to consolidated financial statements (collectively referred to as
the consolidated financial statements) for the years ended December 31, 2021 and
December 31, 2020. In our opinion, the consolidated financial statements present
fairly, in all material respects, the financial position of the Company at
December 31, 2021 and December 31, 2020, and the results of its operations and
its cash flows for the year then ended, in conformity with accounting principles
generally accepted in the United States of America.



Basis for Opinion



These consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on the Company's
consolidated financial statements based on our audits. We are a public
accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and American Institute of Certified Public Accountants
(AICPA) and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.



We conducted our audit in accordance with the standards of the PCAOB and
Generally Accepted Audit Standards (GAAS). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The
Company is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. As part of our audits, we are
required to obtain an understanding of internal control over financial
reporting, but not for the purpose of expressing an opinion on the effectiveness
of the Company's internal control over financial reporting. Accordingly, we
express no such opinion.



Our audit included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included
examining, on a test basis, evidence regarding the amounts and disclosures in
the financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that
our audits provide a reasonable basis for our opinion.

   37


   Contents



The Company's Ability to Continue as a Going Concern



The accompanying consolidated financial statements have been prepared assuming
that the Company will continue as a going concern. As discussed in Note 1 to the
consolidated financial statements, the Company has an accumulated deficit,
recurring losses, and expects continuing future losses, These factors raise
substantial doubt about the Company's ability to continue as a going concern.
Management's evaluation of the events and conditions and management's plans
regarding these matters are also described in Note 1. The consolidated financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.



Critical Audit Matters

The critical audit matters communicated below are matters arising from the
current period audit of the financial statements that were communicated or
required to be communicated to the audit committee and that: (1) relate to
accounts or disclosures that are material to the financial statements and (2)
involved our especially challenging, subjective, or complex judgments. The
communication of critical audit matters does not alter in any way our opinion on
the financial statements, taken as a whole, and we are not, by communicating the
critical audit matters below, providing separate opinions on the critical audit
matters or on the accounts or disclosures to which they relate.



Long-lived asset valuation



As discussed in Note 6 to the consolidated financial statements, the Company
utilizes projections of future cash flows to determine if there are indications
of impairment of long-lived assets, specifically, land, buildings and equipment
which totaled over $2 million as of December 31, 2021.



The Company tests for impairment whenever events or changes in circumstances
indicate that the carrying amount of an asset group may not be recoverable. Such
indicators may include, among others: a significant decline in future cash flows
and changes in expected useful life which relates to the Company's ability and
intent to hold its asset groups for a period of time that recovers their
carrying value.



We identified the valuation of certain long-lived assets to be a critical audit
matter. The valuation is based upon undiscounted future cash flows related to
certain long-lived assets, specifically, land, buildings, and equipment. Whereas
auditor judgments were required to evaluate subjective assumptions in the
Company's analysis of undiscounted cash flows. These included estimated future
revenue and operating expenses. Adverse changes in the assumptions could have a
significant impact on whether an indicator of impairment has been identified and
could have a material impact on the Company's consolidated financial statements.



The following are the primary procedures we performed to address this critical audit matter:

· We obtained an understanding for the Company's process for determining

indicators of impairment of long-lived assets and the Company's evaluation


      of impairment when indicators arose.



· We visited the site of the long-lived assets located that were considered


      high risk for potential impairment.



· We evaluated the reasonableness of the Company's forecasted revenues,

operating results and cash flows by performing an independent sensitivity


      analysis related to the key inputs to forecasted cash flows.





The firm has served this client since December 2018.





/s/ L&L CPAS, PA

L&L CPAS, PA

Certified Public Accountants

Plantation, FL

The United States of America

April 6, 2022

   38


   Contents





                            REAL BRANDS, INC. AND SUBSIDIARIES
                               CONSOLIDATED BALANCE SHEETS
                         DECEMBER 31, 2022 AND DECEMBER 31, 2021

                                                        Audited                Audited
                                                       31-Dec-22              31-Dec-21
ASSETS
CURRENT ASSETS:
Cash and cash equivalents                           $       2,845          $     197,255
Accounts receivables                                          750                    898
Total current assets                                        3,595                198,153

Deposits                                                      530                    530

Property and equipment - net of depreciation            1,157,733          

1,239,809


TOTAL ASSETS                                        $   1,161,859

$ 1,438,492

LIABILITIES AND STOCKHOLDER'S DEFICIT



CURRENT LIABILITIES:
Accounts payable and accrued expenses               $     476,543          $     513,065
Accrued expenses related party                            675,349          

     402,347
Loan payable                                               75,000                     -
Loan payable related party                                273,605                133,605

Convertible note payable related party                    200,000          

     200,000
Notes payable                                              43,003                  7,250
Contingent liabilities                                     45,625                 45,625
TOTAL CURRENT LIABILITIES                               1,789,125              1,301,892

LONG TERM LIABILITIES
Mortgage payable                                          125,629                148,551
Total Long Term Liabilities                               125,629                148,551

TOTAL LIABILITIES                                       1,914,754              1,450,443

STOCKHOLDERS' EQUITY (DEFICIT):
Series A Preferred stock, $.001 par value;
2,000,000 shares authorized, no shares
issued and outstanding as of December 31,
2022, 1,000,000 issued and outstanding as of
December 31, 2021.                                             -           

1,000


Common stock, $.001 par value; 3,998,000,000
shares authorized as of December 31, 2022
and December 31, 2021; 2,690,640,226 shares
issued and outstanding as of December 31,
2022 and 2,677,529,115 shares issued and
outstanding as of December 31, 2021.                    2,690,640          

2,677,529


Common stock subscribed, 6,806,011 shares at
December 31, 2022 and December 31, 2021,
respectively.                                              96,403                 96,403
Additional paid-in capital                              9,034,617              8,881,728
Accumulated deficit                                   (12,574,555 )          (11,668,611 )

TOTAL STOCKHOLDERS' DEFICIT                              (752,895 )              (11,951 )

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 1,161,859 $ 1,438,492



      See the accompanying notes to these audited consolidated financial statements.






   39


   Contents







                              REAL BRANDS, INC. AND SUBSIDIARIES
                             CONSOLIDATED STATEMENTS OF OPERATIONS
                         FOR THE YEAR ENDED DECEMBER 31, 2022 and 2021
                                            AUDITED

                                                           2022                     2021

REVENUE:
Revenues                                            $        11,133           $         5,546
Total revenue                                                11,133                     5,546
Cost of goods sold                                            7,507                   262,620
Gross profit (loss)                                           3,626                  (257,074 )

OPERATING EXPENSES:
General and administrative                                  252,305                   471,494
Professional fees                                           122,570                   194,556
Payroll and related                                         420,112                   326,424
Stock option expense                                             -                  1,065,390
Total operating expenses                                    794,987                 2,057,864

Operating loss                                              791,361                 2,314,938

OTHER INCOME (EXPENSES):
Forgiveness of PPP debt                                          -                    143,485
Depreciation expense                                        (82,076 )                (167,536 )
Loss on disposal of asset                                        -                   (385,989 )
Warrant expense                                                  -                    (37,753 )
Interest expense                                            (32,507 )                 (33,040 )
Total other (expenses) income                              (114,583 )                (480,833 )

LOSS FROM OPERATIONS                                       (905,944  )             (2,795,771 )

PROVISION FOR INCOME TAXES                                       -                         -

NET LOSS                                            $       905,944           $     2,795,771

 BASIC AND DILUTED NET LOSS PER SHARE
ATTRIBUTABLE TO COMMON STOCKHOLDERS                 $          0.00        

$ 0.00


WEIGHTED AVERAGE SHARES OUTSTANDING                   2,680,730,333        

    2,624,071,816

**
Less than $0.01 per share

        See the accompanying notes to these audited consolidated financial statements.




   40


   Contents







                                                                    REAL BRANDS, INC. AND SUBSIDIARIES
                                                        CONSOLIDATED

STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)


                                                              FOR THE YEARS 

ENDED DECEMBER 31, 2021 AND 2022



                                        Preferred Stock                                                    Common        Additional
                                            Series A                         Common Stock                  Stock           Paid-in       Accumulated
                                      Shares          Amount           Shares             Amount         Subscribed        Capital           Deficit            TOTAL

Balance December 31, 2020            1,000,000         1,000        2,358,780,396        2,358,780         414,679        6,794,057         (8,872,840 )         695,676

Issuance for reverse merger                 -             -           164,680,119          164,680        (164,680 )             -                  -                 -
Issuance of common stock for
cash                                        -             -            98,974,969           98,975        (153,595 )      1,039,621                 -            985,001
Cashless exercise of stock
options                                     -             -            55,093,631           55,094              -           (55,094 )               -
Stock options granted pursuant
to the agreements                           -             -                    -                -               -         1,065,390                 -          1,065,390
Warrant expense                             -             -                    -                -               -            37,753                 -             37,753
Net loss for the year ended
December 31, 2021                           -             -                    -                -               -                -          (2,795,771 )      (2,795,771 )

Balance December 31, 2021            1,000,000         1,000       

2,677,529,115        2,677,529          96,403        8,881,728        (11,668,611 )         (11,951 )

Sale of IP                          (1,000,000 )      (1,000 )                 -                -               -             1,000                 -                  0
Issuance of common stock for
cash                                        -             -             3,111,111           13,111              -           151,889                 -            165,000
Net loss for the year ended
December 31, 2022                           -             -                    -                -               -                -            (905,944 )        (905,944 )

Balance December 31, 2022                   -             -        

2,680,640,226 2,690,640 96,403 9,034,617 (12,574,555 ) (752,895 )



                                              See the accompanying notes to 

these audited consolidated financial statements.






   41


   Contents







                           REAL BRANDS, INC. AND SUBSIDIARIES
                         CONSOLIDATED STATEMENTS OF CASH FLOWS
                     FOR THE YEARS ENDED DECEMBER 31, 2022 and 2021
                                        AUDITED

                                                         2022                  2021

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                            $  (905,944  )        $ (2,795,771 )
Adjustments to reconcile net loss to net
cash used in operating activities:
Gain on forgiveness of PPP loan                              -             

  (143,485 )
Option expense                                               -               1,065,390
Warrant expense                                              -                  37,753
Depreciation expense                                     82,076                167,536
Changes in operating assets and liabilities:
Accounts receivable                                         148                   (721 )
Impairment of assets                                         -                 385,989
Inventory                                                    -                 230,951

Accounts payable and accrued expenses                   292,233            

186,696


Net cash used in operating activities                  (531,488 )          

(865,664 )



CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment                           -                (147,999 )
Net cash provided by (used in) investing
activities                                                   -             

(147,999 )



CASH FLOWS FROM FINANCING ACTIVITIES:
Loan payable                                             75,000                     -
Loan payable related party                              140,000                     -
Repayment of mortgage payable                           (22,922 )              (21,975 )
Principal payments on debt                              (20,000 )                   -

Proceeds from sale of common stock                      165,000            

985,001


Net cash provided by financing activities           $   337,078           $

963,026


NET CHANGE IN CASH AND CASH EQUIVALENTS             $  (194,410 )         $

(50,637 )



CASH AND CASH EQUIVALENTS, beginning of
period                                              $   197,255           $

247,892


CASH AND CASH EQUIVALENTS, end of period            $     2,845           $

197,255



SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest                              $     7,732           $      8,686
Cash paid for income taxes                          $        -            $         -

NONCASH INVESTING AND FINANCING ACTIVITIES:
Conversion of account payable to note
payable                                             $   55,753            $

-


Cancellation of preferred stock                     $     1,000

-




     See the accompanying notes to these audited consolidated financial statements.




   42


   Contents






                       REAL BRANDS, INC. AND SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

                           DECEMBER 31, 2022 AND 2021


NOTE 1. ORGANIZATION, BACKGROUND, AND BASIS OF PRESENTATION

Real Brands, Inc. ("Real Brands" or the "Company"), was incorporated under the
laws of the state of Nevada on November 6, 1992. The Company was formed under
the name Mercury Software. From 1997 to 2005 the Company changed its name
several times. On October 10, 2005, the Company changed its name to Global
Beverage Solutions, Inc. and began trading on the OTC Bulletin Board under

the
symbol GBVS.OB.



On October 22, 2013, the Company changed its name to Real Brands, Inc. The
Financial Industry Regulatory Authority ("FINRA") approved Real Brands'
corporate actions regarding its name change and its new stock symbol request and
approved Real Brands' 150:1 Reverse Stock Split. The new symbol was designated
as GBVSD. On November 19, 2013, the ticker symbol changed to RLBD. In August
2014 the Company filed a Form 15 with the US Securities and Exchange Commission
("SEC") terminating the registration of its securities.



On October 22, 2020, the majority of the shareholders of the Company, by written
consent, agreed to a "reverse triangular" merger with CASH Acquisition Corp., a
Delaware corporation and wholly-owned subsidiary of the Company formed for the
purpose of the merger, and Canadian American Standard Hemp Inc., a Delaware
corporation ("CASH"), whereby the Company acquired all of the outstanding shares
of CASH and merged it with and into CASH Acquisition Corp. Real Brands' name and
trading symbol were maintained, with CASH shareholders acquiring majority
control of Real Brands.



The merger was accounted for as a reverse merger, whereby CASH was considered
the accounting acquirer and became our wholly-owned subsidiary. In accordance
with the accounting treatment for a "reverse merger", the Company's historical
financial statements prior to the reverse merger has been replaced with the
historical financial statements of CASH prior to the reverse merger. The
consolidated financial statements after completion of the reverse merger include
the assets, liabilities, and results of operations of the combined company from
and after the closing date of the reverse merger, with only certain aspects of
pre-consummation stockholders' equity remaining in the consolidated financial
statements.


In June 2021 the Company filed a Form 10 with the SEC to register its securities and become a public reporting company.





In March 2023 the Company submitted a Company Related Action Notification Form
notifying FINRA of its intention to implement a reverse stock split of its
common stock in the ratio of 1:20. FINRA has responded with comments and it is
unclear at this time when the Company will be able to implement said reverse
split.



Going concern



The ability of the Company to obtain necessary financing to build its sales,
brand, marketing and distribution and fund ongoing operating expenses is
uncertain. The ability of the Company to generate sales revenue to offset the
expenses and obtain profitability is uncertain. The Company had a net loss as of
December 31, 2022 and 2021, of $905,944 and $2,795,771, respectively. These
material uncertainties cast doubt on the Company's ability to continue as a
going concern. In the event the Company's revenues do not significantly
increase, the Company will require additional financing from time to time, which
it intends to obtain through the issuance of common shares, debt, bonds, grants
and other financial instruments. While the Company has been successful in
raising funds through the issuance of common shares and obtaining debt in the
past, there is no assurance that it will be able to obtain adequate financing in
the future or that such financing will be available on acceptable terms and
while the Company believes that its revenues will increase it does not currently
expect them to generate sufficient cash in the immediate future.

   43


   Contents




Liquidity



As of December 31, 2022, the Company had cash and cash equivalents of a $2,845
as compared to $197,255 as of December 31, 2021, representing a decrease of
$194,410. As of December 31, 2022, the Company had a working capital deficit of
$1,785,530 as compared to a working capital deficit of $1,103,739 as of December
31, 2021, representing an increase in the deficit of $681,791.

Plans with respect to its liquidity management include the following:

• The Company is seeking additional capital in the private and/or public

equity markets to continue operations and build sales, marketing, brand

and distribution. The Company is currently evaluating additional equity

and debt financing opportunities and may execute them when appropriate.

However, there can be no assurances that the Company can consummate such a


        transaction or consummate a transaction at favorable pricing.




    •   The Company plans on increased sales of its products in the market.

However, there can be no assurances that the sales will increase or that

even if they do increase that it will increase sufficiently to generate


        the necessary cash.



NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Principles of Consolidation


The Company's consolidated financial statements and the notes thereto have been
prepared in accordance with Generally Accepted Accounting Principles ("GAAP") in
the United States of America. The consolidated financial statements include Real
Brands, and its wholly owned subsidiaries. DePetrillo Real Estate Holdings, LLC
is a wholly owned subsidiary of CASH Acquisition Corp. and the owner of the
Company's building in Rhode Island. American Standard Hemp Inc. is a wholly
owned subsidiary of CASH Acquisition Corp. and holds the hemp licenses in Rhode
Island. All significant intercompany accounts and transactions have been
eliminated.



Use of estimates and judgments





The preparation of financial statements in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the consolidated financial statements and the reported amounts of
expenses during the reporting period. Key areas of estimation include the
estimated useful lives of property, plant, equipment and intangibles assets and
liabilities, income taxes, and the valuation of stock-based compensation. Due to
the uncertainty inherent in such estimates, actual results may differ from

the
Company's estimates.



   44


   Contents




Accounting standard updates



From time to time, new accounting pronouncements are issued by the Financial
Accounting Standards Board ("FASB") or other standard setting bodies that are
adopted by the Company as of the specified effective date. Unless otherwise
discussed, the Company believes that the effect of recently issued standards
that are not yet effective will not have a material effect on its consolidated
financial position or results of operations upon adoption.

Segment Reporting





The Company operates as one segment, in which management uses one measure of
profitability, and all of the Company's assets are located in the United States
of America. The Company does not operate separate lines of business or separate
business entities with respect to any of its product candidates. Accordingly,
the Company does not have separately reportable segments.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be a cash equivalent.

Accounts Receivable and Allowance for Doubtful Accounts





The Company performs periodic credit evaluations of its customers' financial
conditions and generally does not require collateral. The Company reviews all
outstanding accounts receivable for collectability on a quarterly basis. An
allowance for doubtful accounts is recorded for any amounts deemed
uncollectable. The Company does not accrue interest receivable on past due
accounts receivable.



Concentrations of Credit Risk





The Company, from time to time during the years covered by these consolidated
financial statements, may have bank balances in excess of its insured limits.
Management has deemed this a normal business risk.



Inventory



Inventory is comprised of raw hemp and hemp oil in different phases of
production to completion of final product. Products include tinctures, creams
and lotions. Inventory is valued at cost. No packaging material of any kind is
included in inventory. Packaging materials are expensed as incurred.



Property and Equipment



On February 15, 2020 the Company purchased DePetrillo Real Estate Holdings, LLC,
a Rhode Island Limited Liability Company having as it's only asset the building
at 12 Humbert Street in North Providence Rhode Island. The building is the
Company's headquarters and a hemp processing facility. The purchase price of the
building was 2 million shares of CASH common stock, $25,000 in cash and the
assumption of the mortgage which at the time was $189,916. The prior owner
agreed to put the $25,000 payment into building improvements. The building and
land were appraised at $475,000. The building is being depreciated over 15 years
on a straight-line basis starting October 1, 2021, the date building
improvements were completed. Depreciation expense on the building for the year
ended December 31, 2022 was $29,687.



Building improvements is being depreciated over 15years commencing from the completion of the work, October 1, 2021. Depreciation expense on building improvements for the year ended December 31, 2022 was $52,388.





   45


   Contents




Property and equipment are recorded at cost. Depreciation is computed using the
straight-line method over estimated useful lives of five years. On December 31,
2021 the Company wrote down the value of the equipment to $0 because the
equipment had been sitting idle for over a year resulting in a loss on disposal
of assets of $385,989. The furniture and equipment and related accumulated
depreciation were removed from the books as of December 31, 2021. Expenditures
for repairs and maintenance are expensed as incurred.

Impairment of Long-Lived Assets





The Company reviews long-lived assets, including property and equipment, for
impairment whenever events or changes in business circumstances indicate that
the carrying amount of the assets may not be fully recoverable. Factors that the
Company considers in deciding when to perform an impairment review include
significant underperformance of the business in relation to expectations,
significant negative industry or economic trends, and significant changes or
planned changes in the use of the assets. If an impairment review is performed
to evaluate long-lived asset for recoverability, the Company compares forecasts
of undiscounted cash flows expected to result from the use and eventual
disposition of the long-lived asset to its carrying value. An impairment loss
would be recognized when estimated undiscounted future cash flows expected to
result from the use of an asset over its fair value, determined based on
discounted cash flows is less than the carrying value on the books of the
Company.



Revenue Recognition



The Company follows, ASC 606 Revenue from Contracts with Customers which
establishes a single and comprehensive framework and sets out how much revenue
is to be recognized, and when. The core principle is that a vendor should
recognize revenue to depict the transfer of promised goods or services to
customers in an amount that reflects the consideration to which the vendor
expects to be entitled in exchange for those goods or services. Revenue will now
be recognized by a vendor when control over the goods or services is transferred
to the customer. In contrast, Revenue based revenue recognition is around an
analysis of the transfer of risks and rewards; this now forms one of a number of
criteria that are assessed in determining whether control has been transferred.
The application of the core principle in ASC 606 is carried out in five steps:
Step 1 - Identify the contract with a customer: a contract is defined as an
agreement (including oral and implied), between two or more parties, that
creates enforceable rights and obligations and sets out the criteria for each of
those rights and obligations. The contract needs to have commercial substance
and it is probable that the entity will collect the consideration to which it
will be entitled. Step 2 - Identify the performance obligations in the contract:
a performance obligation in a contract is a promise (including implicit) to
transfer a good or service to the customer. Each performance obligation should
be capable of being distinct and is separately identifiable in the contract.
Step 3 - Determine the transaction price: transaction price is the amount of
consideration that the entity can be entitled to, in exchange for transferring
the promised goods and services to a customer, excluding amounts collected on
behalf of third parties. Step 4 - Allocate the transaction price to the
performance obligations in the contract: for a contract that has more than one
performance obligation, the entity will allocate the transaction price to each
performance obligation separately, in exchange for satisfying each performance
obligation. The acceptable methods of allocating the transaction price include
adjusted market assessment approach, expected cost plus a margin approach, and
the residual approach in limited circumstances. Discounts given should be
allocated proportionately to all performance obligations unless certain criteria
are met and reallocation of changes in standalone selling prices after inception
is not permitted. Step 5 - Recognize revenue as and when the entity satisfies a
performance obligation: the entity should recognize revenue at a point in time,
except if it meets any of the three criteria, which will require recognition of
revenue over time: the entity's performance creates or enhances an asset
controlled by the customer, the customer simultaneously receives and consumes
the benefit of the entity's performance as the entity performs, and the entity
does not create an asset that has an alternative use to the entity and the
entity has the right to be paid for performance to date.

   46


   Contents




Stock-based Compensation


The Company expenses stock-based compensation to employees and consultants based on the fair value at grant date, which generally is the agreement date the Company entered into with employees or consultants. To date the Company has issued restricted common stock shares and preferred stock.

Beneficial Conversion Features of Convertible Securities


Conversion options that are not bifurcated as a derivative pursuant to ASC 815
and not accounted for as a separate equity component under the cash conversion
guidance are evaluated to determine whether they are beneficial to the investor
at inception (a beneficial conversion feature) or may become beneficial in the
future due to potential adjustments. The beneficial conversion feature guidance
in ASC 470-20 applies to convertible stock as well as convertible debt which are
outside the scope of ASC 815. A beneficial conversion feature is defined as a
nondetachable conversion feature that is in the money at the commitment date.
The beneficial conversion feature guidance requires recognition of the
conversion option's in-the-money portion, the intrinsic value of the option, in
equity, with an offsetting reduction to the carrying amount of the instrument.
The resulting discount is amortized as a dividend over either the life of the
instrument, if a stated maturity date exists, or to the earliest conversion
date, if there is no stated maturity date. If the earliest conversion date is
immediately upon issuance, the dividend must be recognized at inception. When
there is a subsequent change to the conversion ratio based on a future
occurrence, the new conversion price may trigger the recognition of an
additional beneficial conversion feature on occurrence.



Derivatives



The Company reviews the terms of convertible debt issued to determine whether
there are embedded derivative instruments, including embedded conversion
options, which are required to be bifurcated and accounted for separately as
derivative financial instruments. In circumstances where the host instrument
contains more than one embedded derivative instrument, including the conversion
option, that is required to be bifurcated, the bifurcated derivative instruments
are accounted for as a single, compound derivative instrument.



Bifurcated embedded derivatives are initially recorded at fair value and are
then revalued at each reporting date with changes in the fair value reported as
non-operating income or expense. When the equity or convertible debt instruments
contain embedded derivative instruments that are to be bifurcated and accounted
for as liabilities, the total proceeds received are first allocated to the fair
value of all the bifurcated derivative instruments. The remaining proceeds, if
any, are then allocated to the host instruments themselves, usually resulting in
those instruments being recorded at a discount from their face value. The
discount from the face value of the convertible debt, together with the stated
interest on the instrument, is amortized over the life of the instrument through
periodic charges to interest expense.

Net Loss Per Common Share





Basic net loss per common share is computed by dividing net loss by the
weighted-average number of common shares outstanding during the period.
Potential common stock equivalents are determined using the treasury stock
method. For diluted net loss per share purposes, the Company excludes stock
options and other stock-based awards, including shares issued as a result of
option exercises that are subject to repurchase by the Company, whose effect
would be anti-dilutive from the calculation. During the years ended December 31,
2022 and 2021, common stock equivalents were excluded from the calculation of
diluted net loss per common share, as their effect was anti-dilutive due to the
net loss incurred. Therefore, basic and diluted net loss per share was the

same
in all periods presented.

   47


   Contents




The Company had 154,518,887 and 30,192,079 potentially dilutive options and
convertible securities, respectively, that have been excluded from the
computation of diluted weighted-average shares outstanding as of December 31,
2022, and 154,518,887 and 28,443,298 potentially dilutive options and
convertible securities, respectively, that have been excluded from the
computation of diluted weighted-average shares outstanding as of December 31,
2021, as they would be anti-dilutive.



Treasury Stock


The Company accounts for treasury stock under the cost method and includes treasury stock as a component of stockholder's deficit.

Fair Value of Financial Instruments


The guidance for fair value measurements, ASC 820, Fair Value Measurements and
Disclosures, establishes the authoritative definition of fair value, sets out a
framework for measuring fair value, and outlines the required disclosures
regarding fair value measurements. Fair value is the price that would be
received to sell an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in an orderly
transaction between market participants at the measurement date. The Company
uses a three-tier fair value hierarchy based upon observable and non-observable
inputs as follow:


• Level 1 - Quoted market prices in active markets for identical assets and


        liabilities;



• Level 2 - Inputs, other than level 1 inputs, either directly or indirectly


        observable; and




      • Level 3 - Unobservable inputs developed using internal estimates and
        assumptions (there is little or no market date) which reflect those that
        market participants would use.


The Company records its derivative activities at fair value. As of December 31, 2021, no derivative liabilities are recorded.

Off Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.





Uncertain Tax Positions



The Company did not take any uncertain tax positions and had no adjustments to
unrecognized income tax liabilities or benefits pursuant to the provisions of
Section 740-10-25 for the year ended December 31, 2022.



 Income Taxes



The Company accounts for income taxes under Section 740-10-30 of the FASB
Accounting Standards Codification. Deferred income tax assets and liabilities
are determined based upon differences between the financial reporting and tax
basis of assets and liabilities and are measured using the enacted tax rates and
laws that will be in effect when the differences are expected to reverse.
Deferred tax assets are reduced by a valuation allowance to the extent
management concludes it is more likely than not that the assets will not be
realized. Deferred tax assets and liabilities are measured using enacted tax
rates expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled.

   48


   Contents

The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of operations in the period that includes the enactment date.

Recent Accounting Pronouncements

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements, and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.





The Company accounts for stock-based compensation for employees and directors in
accordance with Accounting Standards Codification 718, Compensation ("ASC 718")
as issued by the FASB. ASC 718 requires all share-based payments to employees,
including grants of employee stock options, to be recognized in the statement of
operations based on their fair values. Under the provisions of ASC 718,
stock-based compensation costs are measured at the grant date, based on the fair
value of the award, and are recognized as an expense over the employee's
requisite service period (generally the vesting period of the equity grant). The
fair value of the Company's common stock options are estimated using the Black
Scholes option-pricing model with the following assumptions: expected
volatility, dividend rate, risk free interest rate and the expected life. The
Company expenses stock-based compensation by using the straight-line method. In
accordance with ASC 718 and, excess tax benefits realized from the exercise of
stock-based awards are classified as cash flows from operating activities. All
excess tax benefits and tax deficiencies (including tax benefits of dividends on
share-based payment awards) are recognized as income tax expense or benefit in
the condensed consolidated statements of operations. The Company accounts for
stock-based compensation awards issued to non-employees for services, as
prescribed by ASC 718-10, at either the fair value of the services rendered or
the instruments issued in exchange for such services, whichever is more readily
determinable, using the measurement date guidelines enumerated in Accounting
Standards Update ("ASU") 2018-07.



In February 2016, the FASB issued ASU 2016-02, "Leases" Topic 842, which amends
the guidance in former ASC Topic 840, Leases. The new standard increases
transparency and comparability most significantly by requiring the recognition
by lessees of right-of-use assets and lease liabilities on the balance sheet for
all leases longer than 12 months. Under the standard, disclosures are required
to meet the objective of enabling users of financial statements to assess the
amount, timing, and uncertainty of cash flows arising from leases. For lessees,
leases will be classified as finance or operating, with classification affecting
the pattern and classification of expense recognition in the income statement.
The Company adopted the new lease guidance effective January 1, 2019. The
Company is not a party to any leases and therefore is not showing any asset or
liability related to leases in the current period or prior periods.



In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic
832). The amendments within the update require certain disclosures about
transactions with a government that are accounted for by applying a grant or
contribution accounting model by analogy. The amendments will require disclosure
of information about the nature of the transactions and the related accounting
policy used to account for the transactions, information regarding the line
items within the consolidated financial statements that are affected by the
transactions, and significant terms and conditions of the transactions. The
amendments in the update will be effective for financial statements issued for
annual periods beginning after December 15, 2021, with early adoption permitted.
The Company's adoption of this ASU did not have a material impact on the
Company's consolidated financial statements or results of options.





ASC 740 prescribes a comprehensive model for how companies should recognize,
measure, present, and disclose in their financial statements uncertain tax
positions taken or expected to be taken on a tax return. Under ASC 740, tax
positions must initially be recognized in the financial statements when it

is
more likely



   49


   Contents






than not the position will be sustained upon examination by the tax authorities.
Such tax positions must initially and subsequently be measured as the largest
amount of tax benefit that has a greater than 50% likelihood of being realized
upon ultimate settlement with the tax authority assuming full knowledge of the
position and relevant facts.



Subsequent Events



In March 2023, for each of the years 2021, 2022 and 2023, for which no
compensation was given to the directors, each non-employee director was granted,
as compensation for serving as a director, five-year non-qualified stock options
to purchase 6,143,628 shares of the Company's common stock at an exercise price
equal to the last reported trading price of our common stock on the day of grant
(i.e. 3/22/23), with the options granted for 2021 and 2022 vesting immediately
and the options granted for 2023 to vest on December 31, 2023, provided the
director serves for at least six months, following the date of grant. In
addition to these option grants, each director shall receive an additional
500,000 options to vest on December 31, 2023, provided the director serves for
at least six months, following the date of grant. Total options granted to
Directors was 94,654,420at an exercise price of $0.0071.



In March 2023 as consideration for deferring his compensation over the last two
years, Thom Kidrin the Chairman and CEO was granted five-year non-qualified
stock options to purchase 50,000,000 shares of the Company's common stock at an
exercise price equal to the last reported trading price of our common stock on
the date of grant (i.e. 3/22/23) and to vest immediately. Exercise price is
$0.0071.



On December 21, 2022, the Company received written notice from the OTC Markets
Group ("OTC") notifying the Company that its common shares, $0.001 par value,
closed below $0.01 per share for more than 30 consecutive calendar days and no
longer meets the Standards for Continued Eligibility for OTCQB as per the OTCQB
Standards, Section 2.3(2), which states that the Company must "maintain
proprietary priced quotations published by a Market Maker in OTC Link with a
minimum closing bid price of $.01 per share on at least one of the prior thirty
consecutive calendar days." As per Section 4.1 of the OTCQB Standards, the
Company was granted a cure period of 90 calendar days during which the minimum
closing bid price for the Company's common stock must be $0.01 or greater for
ten consecutive trading days in order to continue trading on the OTCQB
marketplace.



This requirement was not met by March 22, 2023, so the Company's common stock was removed from the OTCQB marketplace.





The Company evaluates events that have occurred after the balance sheet date but
before the financial statements are issued. Based upon the evaluation, the
Company did not identify any additional recognized or non-recognized subsequent
events that would have required adjustment or disclosure in the financial
statements.




NOTE 3. ACCOUNTS RECEIVABLES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

At December 31, 2022 the Company has $750 in accounts receivables. The Company did not have an allowance for doubtful accounts at December 31, 2022. The balance in the account was received during the first quarter of 2023. The Company does not accrue interest receivable on past due accounts receivable.





   50


   Contents




NOTE 4. INVENTORY



At December 31, 2022 the inventory was $0. The inventory had not moved for over
a year due to the pandemic and renovations to the facility. As a result, the
inventory that was at the facility was written off in 2021. Inventory is
comprised of hemp oil in different phases of production to completion of final
product. Products include tinctures, creams and lotions. Inventory is valued at
cost. No purchases of pre-packaged products or packaging material is included in
inventory. Pre-packaged products and packaging materials are expensed as
incurred.

NOTE 5. DEPOSITS


The Company has a deposit in the amount of $530 with a utility company.

NOTE 6. PROPERTY AND EQUIPMENT

Property and equipment is comprised of a building and land, building improvements and furniture and equipment.

The building and land were appraised at $475,000. The building is being depreciated over 15 years on a straight-line basis starting October 1, 2021, the date the building improvements were completed on the building. Depreciation expense on the building for the year ended December 31, 2022 was $29,687.

Building improvements is being depreciated over 15 years commencing from the completion of the work, October 1, 2021. Depreciation expense on building improvements for the year ended December 31, 2022 was $52,388.


Property and equipment are recorded at cost. Depreciation is computed using the
straight-line method over estimated useful lives of five years. On December 31,
2021 the Company wrote down the value of the equipment to $0 because the
equipment had been sitting idle for over a year. The furniture and equipment and
related accumulated depreciation were removed from the books as of December 31,
2021. Expenditures for repairs and maintenance are expensed as incurred.




                                  December 31,     December 31,
                                      2022             2021

Building                         $    475,000     $    475,000
Building Improvements                 785,823          785,823
Furniture and Equipment                    -           752,553
Gross fixed assets                  1,260,823        2,013,376
Less: Accumulated Depreciation        103,089          387,578
Less: Impairments                          -           385,989
Net Fixed Assets                 $  1,157,733     $  1,239,809




   51


   Contents





NOTE 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES





Accounts payable and accrued expenses include normal operating expenses,
professional fees and costs remaining to be paid for the build out of the new
facility. Included in accrued expenses is a balance for ATS Indian Trace, LLC.
ATS Indian Trace, LLC v. the Company was a civil action filed by ATS Indian
Trace, LLC in the Circuit Court of Broward County, Florida on July 22, 2015. On
November 18, 2015, a (default) Final Judgement was entered in favor of ATS
Indian Trace, LLC and against the Company in the amount of $71,069.37. This
judgement is currently outstanding and remains due and owing. ATS Indian Trace,
LLC has not taken any enforcement action against the Company for several years.
The balance is included in accrued expenses even though the Company does not
expect to ever have to pay it.

 Schedule of Accounts Payable and Accrued
Liabilities
                                                        December 31,                December 31,
                                                            2022                        2021

Accounts payable                                    $    98,720                 $   154,758
Accrued expenses                                        371,935                     344,410
Accrued interest                                          3,621                       7,330
Credit cards payable                                      2,267                       6,568

Total accounts payable and accrued expenses                   $  476,543
              $  513,065

NOTE 8. ACCRUED EXPENSES - RELATED PARTY

At December 31, 2022, accrued expenses related parties was $675,349.





Such amount included, to its CEO, Thom Kidrin, $417,308 in accrued salary and
$30,308 in accrued interest on a loan with principal balance of $273,605 (see
Note 9) and an additional $45,733 in accrued interest on a convertible note from
Worlds Inc., with a principal balance of $200,000 (see Note 10). In addition,
the Company owed $175,000 to its CFO, Chris Ryan and $7,000 to Dr. Rammal.




NOTE 9. MORTGAGE PAYABLE


As of December 31, 2022, the following mortgage was outstanding:




                             Mortgage payable       Accrued interest

Mortgage payable (6.31%)              125,629                     -
Total                      $          125,629     $               -



NOTE 10. LOAN PAYABLE - RELATED PARTY

A loan was provided by the CEO, Thom Kidrin, at an interest rate of 7%. The loan balance at December 31, 2022 was $273,605 with accrued interest of $30,308.





   52


   Contents





NOTE 11. CONVERTIBLE NOTES PAYABLE - RELATED PARTY





The Company has issued a convertible note payable related party in the amount of
$200,000.  The convertible note has a 7% annual interest rate and matured on
October 15, 2021. Interest and principal are payable at maturity. The note can
be converted at any time and either all or part of the amount due into equity at
a price of $0.50 per share. If converted into common stock, the related party
would own 1% of Company based upon the current number of shares outstanding. The
related party holding the convertible note is Worlds Inc. Messrs. Kidrin,
Toboroff and Christos are Directors of Worlds Inc. and Mr. Kidrin is the CEO and
Mr. Ryan is the CFO of Worlds Inc. On October 15, 2021, the convertible note was
extended to October 15, 2023.  All other terms remain the same.  As
consideration for extending the maturity date two years, the Company issued one
million warrants to purchase the Company's stock at a purchase price $0.05 per
share.  The Company recorded a warrant expense of $37,753 for the warrants
granted with the extension.



As of December 31, 2022, the Company incurred $45,733 in interest expense on the convertible note.

NOTE 13. STOCKHOLDER'S EQUITY





Common Stock



In the third quarter of 2022, the Company sold 3,111,111shares with net proceeds
of $65,000 through private placements. In the fourth quarter of 2022, the
Company sold 10,000,000 shares with net proceeds of $100,000 through private
placements.


As of December 31, 2022, the Company had 2,690,640,226shares of its common stock outstanding.





Series A Preferred Stock



On January 20, 2022, the Company entered into a purchase agreement with its
former CEO Jerome Pearring in which the Company sold certain trademarks and its
subsidiary Real brands Venture Group Inc. to Mr. Pearring and returned to the
Company his 1,000,000 shares of Series A Preferred stock for cancellation.




NOTE 14. STOCK OPTIONS


The Company has outstanding the following stock options as of December 31, 2022.




             Exercise Price per Share        Shares Under Option/warrant         Remaining Life in Years
Outstanding
$                           0.011                              4,000,000                         2.25
$                          0.0267                             12,287,256                         2.00
$                          0.0267                             92,154,421                         2.75
$                          0.0267                             46,077,210                         2.83
Total                                                        154,518,887
Exercisable
$                           0.011                              4,000,000                         2.25
$                          0.0267                             12,287,256                         2.00
$                          0.0267                             92,154,421                         2.75
$                          0.0267                             46,077,210                         2.83
Total                                                        154,518,887






   53


   Contents





NOTE 15. COMMITMENTS AND CONTINGENCIES





The Company is committed to an employment agreement with Thom Kidrin, its
President and CEO. Mr. Kidrin entered into the employment agreement with CASH on
November 26, 2018. The employment agreement provides for a base salary of
$175,000 per year. Mr. Kidrin is entitled to participate in any stock, stock
option or other equity participation plan and any profit-sharing, pension,
retirement, insurance, or other employee benefit plan generally available to the
executive officers of the Company.



CASH signed an Agreement and Plan of Merger with Purist Acquisition LLC, Purist
LLC and Michael S. Metcalfe ("MSM"). Upon consummation of the Merger, CASH will
receive ownership rights of all intellectual property related to Purist's
simulated moving bed chromatography technology and will be obligated to the
following payments: (i) A cash payment of $90,000, (ii) A certificate
representing Seven Hundred Fifty Thousand (750,000) shares of the Company's
Common Stock (or appropriate alternative arrangements if uncertificated shares
of Seven Hundred Fifty Thousand (750,000) shares of Company Common Stock
represented by book-entry shares will be issued), (iii) A fully vested option to
acquire One Hundred Fifty Thousand (150,000) shares of the Company's Common
Stock (the "Option"). The Option shall be exercisable for three years following
the date the Company's Common Stock becomes publicly traded through a stock
exchange or is listed for trading through an electronic quotation and trading
service. The exercise price for the Option shall be the lower of (x) $0.50 per
share or (y) the price per share equal to a 25% discount of the offering price
of the Company's first public or private offering of its Common Stock following
the Closing which raises at least Five Hundred Thousand Dollars ($500,000), and
(iv) An additional cash payment of Fifty Thousand Dollars ($50,000) to be paid
as follows: Within thirty (30) days of its fiscal year end, the Company will
deliver an amount equal to one (1%) percent of its net income up to a maximum
payment of Fifty Thousand Dollars ($50,000). In the event one (1%) percent of
the Company's net income for the fiscal year ended December 31, 2019, does not
equal $50,000, then the process shall be repeated at the close of each
successive fiscal year until such time as an aggregate of Fifty Thousand Dollars
($50,000) has been delivered to MSM. In addition, on the Closing of the Merger,
Company shall enter into a consulting agreement with MSM providing for a monthly
fee of $3,500 for a period of twelve (12) months. In connection with his
consultancy, MSM will enter into (1) an assignment of inventions agreement
assigning ownership rights of all intellectual property related to Purist's
simulated moving bed chromatography technology developed and/or created by MSM
during the term of his consultancy and (2) a non-competition agreement pursuant
to which MSM will agree to not compete with the Company during the term of his
consultancy or within twelve (12) months after termination of his consultancy.



NOTE 16 - INCOME TAXES



At December 31, 2022, the Company had federal and state net operating loss carry
forwards of approximately $5,482,345 that expire in various years through the
year 2042.


Due to net operating loss carry forwards and operating losses, there is no provision for current federal or state income taxes for the years ended December 31, 2022 and 2021.

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for federal and state income tax purposes.





   54


   Contents






The Company's deferred tax asset at December 31, 2022 consists of net operating
loss carry forwards calculated using federal and state effective tax rates
equating to approximately $5,482,345 less a valuation allowance in the amount of
approximately $5,482,345. Because of the Company's lack of earnings history, the
deferred tax asset has been fully offset by a valuation allowance. The valuation
allowance increased by approximately $235,545 for the year ended December 31,
2022 and increased by approximately $287,504 for the year ended December 31,
2021.


The Company's total deferred tax asset as of December 31, 2022, and 2021 are as follows:





                                         2022             2021
Net operating loss carry forwards      5,482,345        5,246,800
Valuation allowance                   (5,482,345 )     (5,246,800 )
Net deferred tax asset                        -                -






The reconciliation of income taxes computed at the federal and state statutory
income tax rate to total income taxes for the years ended December 31, 2022

and
2021 is as follows:


                                                      2022       2021

Income tax computed at the federal statutory rate 21 % 21 % Income tax computed at the state statutory rate 5 % 5 % Valuation allowance

                                   (26 )%     (26 )%
Total deferred tax asset                               -          -




On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted
into law and the new legislation contains several key tax provisions that
affected us, including a one-time mandatory transition tax on accumulated
foreign earnings and a reduction of the corporate income tax rate to 21%
effective January 1, 2018, among others. We are required to recognize the effect
of the tax law changes in the period of enactment, such as determining the
transition tax, remeasuring our U.S. deferred tax assets and liabilities as well
as reassessing the net realizability of our deferred tax asset and liabilities.
In December 2017, the SEC staff issued Staff Accounting Bulletin No. 118, Income
Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), which allows
us to record provisional amounts during a measurement period not to extend
beyond one year of the enactment date.



   55


   Contents






NOTE 17. SUBSEQUENT EVENTS





In March 2023, for each of the years 2021, 2022 and 2023, for which no
compensation was given to the directors, each non-employee director was granted,
as compensation for serving as a director, five-year non-qualified stock options
to purchase 6,143,628 shares of the Company's common stock at an exercise price
equal to the last reported trading price of our common stock on the day of grant
(i.e. 3/22/23), with the options granted for 2021 and 2022 vesting immediately
and the options granted for 2023 to vest on December 31, 2023, provided the
director serves for at least six months, following the date of grant. In
addition to these option grants, each director shall receive an additional
500,000 options to vest on December 31, 2023, provided the director serves for
at least six months, following the date of grant. Total options granted to
Directors was 94,654,420at an exercise price of $0.0071.



In March 2023 as consideration for deferring his compensation over the last two
years, Thom Kidrin the Chairman and CEO was granted five-year non-qualified
stock options to purchase 50,000,000 shares of the Company's common stock at an
exercise price equal to the last reported trading price of our common stock on
the date of grant (i.e. 3/22/23) and to vest immediately. Exercise price is
$0.0071.



On December 21, 2022, the Company received written notice from the OTC Markets
Group ("OTC") notifying the Company that its common shares, $0.001 par value,
closed below $0.01 per share for more than 30 consecutive calendar days and no
longer meets the Standards for Continued Eligibility for OTCQB as per the OTCQB
Standards, Section 2.3(2), which states that the Company must "maintain
proprietary priced quotations published by a Market Maker in OTC Link with a
minimum closing bid price of $.01 per share on at least one of the prior thirty
consecutive calendar days." As per Section 4.1 of the OTCQB Standards, the
Company was granted a cure period of 90 calendar days during which the minimum
closing bid price for the Company's common stock must be $0.01 or greater for
ten consecutive trading days in order to continue trading on the OTCQB
marketplace.



This requirement was not met by March 22, 2023, so the Company's common stock was removed from the OTCQB marketplace.





The Company evaluates events that have occurred after the balance sheet date but
before the financial statements are issued. Based upon the evaluation, the
Company did not identify any additional recognized or non-recognized subsequent
events that would have required adjustment or disclosure in the financial
statements, except as disclosed.



   56


   Contents

© Edgar Online, source Glimpses